Advances in allogeneic hematopoietic stem cell transplantation for Langerhans cell histiocytosis in children
Langerhans cell histiocytosis (LCH) is a disease caused by clonal expansion of CD1a+/CD207+ cells and is characterized by organ involvement and dysfunction. Treatment of LCH in children is risk-adapted, and multisystem LCH requires systemic therapy. Although systemic treatments such as chemotherapy...
Saved in:
| Main Authors: | Guangqiang Meng, Saran Feng, Yan Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-01-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1345855/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A case of Langerhans cell histiocytosis mimicking child abuse
by: Şakire Başer, et al.
Published: (2016-12-01) -
Case of congenital Langerhans cells histiocytosis in an infant
by: T. T. Valiev, et al.
Published: (2014-07-01) -
Pulmonary involvement in children with Langerhans cell histiocytosis
by: Çağrı Coşkun, et al.
Published: (2024-07-01) -
Outcome of allogeneic Hematopoietic Stem Cell Transplantation on Diamond-Blackfan anemia using busulfan-based myeloablative regimen
by: Maryam Behfar, et al.
Published: (2019-06-01) -
Langerhans Cell Histiocytosis in Children: Literature Review
by: Evgeniy A. Burtsev, et al.
Published: (2023-02-01)